🇫🇷 France Country × Condition
breast cancer Clinical Trials in France
Active clinical trials for breast cancer with research sites in France. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 10 // Recruiting: 10 Phases: Phase 3, Phase 2 // Updated: Daily
Total Trials
10
Recruiting Now
10
Country
🇫🇷 France
Active Trials in France (10)
NCT06415266
Recruiting
Assessment the sExual Quality of Life in Breast Cancer Patients Receiving oncoSexology Supportive Care on Proactive Versus On-request
Enrollment
264 pts
Country
🇫🇷 France
Institut du Cancer de Montpellier -...
View Trial → NCT05232916 Phase 3
Recruiting
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects
Enrollment
2,250 pts
Country
🇫🇷 France
Greenwich LifeSciences, Inc.
View Trial → NCT07593976 Phase 2
Recruiting
Evaluation of [68Ga]Ga-NOTA-anti-HER2-sdAb PET/CT for Predicting Pathological Complete Response After Neoadjuvant Chemotherapy in HER2 Positive Early Breast Cancer
Enrollment
42 pts
Country
🇫🇷 France
Centre Henri Becquerel
View Trial → NCT06299202
Recruiting
Contrast-enhanced Spectral Mammography (CESM) Early Quantitative Evaluation of Tumoral Response and Pathologic Complete Response Prediction for Localized Breast Cancer Treated by Neoadjuvant Chemotherapy
Enrollment
100 pts
Country
🇫🇷 France
Hospices Civils de Lyon
View Trial → NCT05983432 Phase 1
Recruiting
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
Enrollment
470 pts
Country
🇫🇷 France
SystImmune Inc.
View Trial → NCT07436312
Recruiting
Impact of Consumption of Ultra-processed Foods in Individuals at High Risk of Cancer
Enrollment
170 pts
Country
🇫🇷 France
Gustave Roussy, Cancer Campus, Gran...
View Trial → NCT03787056
Recruiting
Predictive Value of Progastrin Titer at Diagnosis and of Progastrin Kinetics During Treatment in Cancer Patients
Enrollment
410 pts
Country
🇫🇷 France
Hospices Civils de Lyon
View Trial → NCT06906601
Recruiting
Preoperative Magnetic Tracking in Breast Surgery in France: French Medical-economic Study.
Enrollment
772 pts
Country
🇫🇷 France
Centre Leon Berard
View Trial → NCT05768139 Phase 1, Phase 2
Recruiting
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
Enrollment
880 pts
Country
🇫🇷 France
Eli Lilly and Company
View Trial → NCT04342546
Recruiting
Predictive Toxicity Test Linked to Radiotherapy After Mastectomy and Immediate Implant Reconstruction
Enrollment
250 pts
Country
🇫🇷 France
Institut du Cancer de Montpellier -...
View Trial → Frequently Asked Questions
How many breast cancer clinical trials are active in France?
There are currently 10 active clinical trials for breast cancer with sites in France, of which 10 are actively recruiting patients.
How can I join a breast cancer clinical trial in France?
To join a breast cancer clinical trial in France, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in France directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are breast cancer trials in France?
Active breast cancer trials in France span Phase 3, Phase 2, Phase 1, Phase 1, Phase 2. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology